165 related articles for article (PubMed ID: 27869176)
1. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium.
Liu P; Weng Y; Sui Z; Wu Y; Meng X; Wu M; Jin H; Tan X; Zhang L; Zhang Y
Sci Rep; 2016 Nov; 6():37606. PubMed ID: 27869176
[TBL] [Abstract][Full Text] [Related]
2. In-Depth Proteomic Quantification of Cell Secretome in Serum-Containing Conditioned Medium.
Weng Y; Sui Z; Shan Y; Jiang H; Zhou Y; Zhu X; Liang Z; Zhang L; Zhang Y
Anal Chem; 2016 May; 88(9):4971-8. PubMed ID: 27042867
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
4. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
[TBL] [Abstract][Full Text] [Related]
5. Metabolic labeling and protein linearization technology allow the study of proteins secreted by cultured cells in serum-containing media.
Colzani M; Waridel P; Laurent J; Faes E; Rüegg C; Quadroni M
J Proteome Res; 2009 Oct; 8(10):4779-88. PubMed ID: 19711906
[TBL] [Abstract][Full Text] [Related]
6. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
[TBL] [Abstract][Full Text] [Related]
7. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches to decipher cancer cell secretome.
Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
[TBL] [Abstract][Full Text] [Related]
10. Proteomic characterisation of pancreatic islet beta-cells stimulated with pancreatic carcinoma cell conditioned medium.
Song G; Cui Y; Zhong N; Han J
J Clin Pathol; 2009 Sep; 62(9):802-7. PubMed ID: 19403515
[TBL] [Abstract][Full Text] [Related]
11. Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.
Papaleo E; Gromova I; Gromov P
Expert Rev Proteomics; 2017 Nov; 14(11):1021-1035. PubMed ID: 28967788
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
McKinney KQ; Lee JG; Sindram D; Russo MW; Han DK; Bonkovsky HL; Hwang SI
Cancer Genomics Proteomics; 2012; 9(5):257-63. PubMed ID: 22990105
[TBL] [Abstract][Full Text] [Related]
13. Secretome proteomics for discovery of cancer biomarkers.
Makridakis M; Vlahou A
J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
[TBL] [Abstract][Full Text] [Related]
14. Secretome protein signature of human pancreatic cancer stem-like cells.
Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
[TBL] [Abstract][Full Text] [Related]
15. Quantitative MS Workflow for a High-Quality Secretome Analysis by a Quantitative Secretome-Proteome Comparison.
Poschmann G; Prescher N; Stühler K
Methods Mol Biol; 2021; 2228():293-306. PubMed ID: 33950499
[TBL] [Abstract][Full Text] [Related]
16. In-depth proteomic profiling of the uveal melanoma secretome.
Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
[TBL] [Abstract][Full Text] [Related]
17. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling.
Chiu KH; Chang YH; Wu YS; Lee SH; Liao PC
J Proteome Res; 2011 Mar; 10(3):1110-25. PubMed ID: 21186846
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
19. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium.
Yamaguchi N; Yamamura Y; Koyama K; Ohtsuji E; Imanishi J; Ashihara T
Cancer Res; 1990 Nov; 50(21):7008-14. PubMed ID: 2208167
[TBL] [Abstract][Full Text] [Related]
20. Expression of acinar and ductal products in Capan-1 cells growing in synthetic serum and serum-free media.
Fernández E; Fallon MJ; Frazier ML; de Llorens R; Cuchillo CM
Cancer; 1994 May; 73(9):2285-95. PubMed ID: 7513248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
